HALOZYME THERAPEUTICS, INC. 401(K) PLAN
ERISA Form 5500 plan record drawn from DOL EBSA — verify with linked source filings below.
HALOZYME, INC.
This 401(k) plan holds $80M in total assets and serves 380 participants as of 2024. It is sponsored by HALOZYME, INC. in California. The plan reported positive net income of $13M for the year.
What the Filing Says About HALOZYME THERAPEUTICS, INC. 401(K) PLAN
HALOZYME THERAPEUTICS, INC. 401(K) PLAN is a 401(k) retirement plan sponsored by HALOZYME, INC., headquartered in California. As of the 2024 Form 5500 filing, the plan reports $80M in total end-of-year assets and covers 380 participants across the Manufacturing industry. The sponsor's EIN on file with the U.S. Department of Labor is 330802801, and the plan has been effective since 2005-04-01. Its filing status is currently FILING RECEIVED.
Year over year, total assets moved from $67M at the beginning of 2024 to $80M at year-end — a gain of 19.8%. Net assets (after liabilities) closed the year at $80M, with reported net income of $13M driven by investment returns, contributions received, and benefit payments during the period. These figures reflect what the plan administrator certified on Schedule H or Schedule I of the Form 5500 annual return and can be compared against 2 prior plan-year filings from the same sponsor shown below.
Asset totals and participant counts reflect a single plan year snapshot and can change materially with market conditions, plan mergers, or workforce changes. Fields such as "net income" include both realized investment performance and contribution/distribution flows — a single-year figure does not by itself indicate plan health or participant outcomes. This page summarizes public DOL disclosures for research and educational purposes only and is not retirement, tax, legal, or financial advice. Before making decisions about your own retirement benefits or evaluating an employer's plan, verify the underlying filing directly via the DOL EFAST2 system and consult a qualified professional.
Financial Summary (2023)
| Total Assets (Beginning of Year) | $67M |
| Total Assets (End of Year) | $80M |
| Net Assets (End of Year) | $80M |
| Net Income | $13M |
| Plan Type | 401(k) |
| Employer EIN | 330802801 |
| Plan Effective Date | 2005-04-01 |
| Filing Status | FILING RECEIVED |
Sponsor Plan History (HALOZYME, INC.)
| Year | Plans | Participants | Total Assets |
|---|---|---|---|
| 2022 | 1 | 141 | $49M |
| 2023 | 1 | 386 | $67M |
| 2024 | 1 | 380 | $80M |
Nearby 401(k) Plans in California
Peer 401(k) plans — same state, same plan type — ranked by total assets.
- WELLS FARGO & COMPANY 401(K) PLAN $51.8B · 193,919
- GOOGLE LLC 401(K) SAVINGS PLAN $39.0B · 122,867
- ORACLE CORPORATION 401(K) SAVINGS AND INVESTMENT PLAN $26.3B · 63,105
- INTEL 401(K) SAVINGS PLAN $22.2B · 59,863
- APPLE 401(K) PLAN $19.8B · 106,111
Related Data
Guides
Related Data on Other Portals
Frequently Asked Questions
How much money is in the HALOZYME THERAPEUTICS, INC. 401(K) PLAN? ▼
What type of plan is HALOZYME THERAPEUTICS, INC. 401(K) PLAN? ▼
Who sponsors the HALOZYME THERAPEUTICS, INC. 401(K) PLAN? ▼
How did HALOZYME THERAPEUTICS, INC. 401(K) PLAN perform in 2024? ▼
Where can I find official filings for HALOZYME THERAPEUTICS, INC. 401(K) PLAN? ▼
How does HALOZYME THERAPEUTICS, INC. 401(K) PLAN compare to other plans? ▼
Explore PlainRetire
Source: U.S. Department of Labor, Employee Benefits Security Administration (EBSA), Form 5500 public disclosure dataset. Plan year 2024.
Source: DOL EFAST2 filing system (efast.dol.gov) — original filing retrieval by EIN 330802801.
Reference: IRS Publication 560 — Retirement Plans for Small Business, contribution-limit rules.
Reference: IRS Publication 590-B — Distributions from IRAs, RMD rules under SECURE Act 2.0.
Read our methodology — how this data is sourced, computed, and verified.